Dr Christopher Nathan Johnson, MD | |
1034 N 500 W, Provo, UT 84604-3380 | |
(801) 357-7850 | |
Not Available |
Full Name | Dr Christopher Nathan Johnson |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 16 Years |
Location | 1034 N 500 W, Provo, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013177328 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Utah Valley Hospital | Provo, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Utah Valley Emergency Physicians Inc | 2860390879 | 34 |
News Archive
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
Researchers have recently used an artificial intelligence (AL) technique to examine how MRI scans can validate how hereditary factors can impact heart function.
Wolters Kluwer Health, a division of Wolters Kluwer, has released the results of a study that looks at key statistical outcomes of the Medicare Part D (MPD) prescription drug program.
The U.S. Food and Drug Administration today issued a Federal Register notice instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone. The notice is part of the FDA's Unapproved Drugs Initiative to remove unapproved new drugs from the market.
› Verified 6 days ago
Entity Name | Utah Valley Emergency Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649204553 PECOS PAC ID: 2860390879 Enrollment ID: O20040727000274 |
News Archive
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
Researchers have recently used an artificial intelligence (AL) technique to examine how MRI scans can validate how hereditary factors can impact heart function.
Wolters Kluwer Health, a division of Wolters Kluwer, has released the results of a study that looks at key statistical outcomes of the Medicare Part D (MPD) prescription drug program.
The U.S. Food and Drug Administration today issued a Federal Register notice instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone. The notice is part of the FDA's Unapproved Drugs Initiative to remove unapproved new drugs from the market.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christopher Nathan Johnson, MD Po Box 10, Spanish Fork, UT 84660-0010 Ph: (801) 253-6554 | Dr Christopher Nathan Johnson, MD 1034 N 500 W, Provo, UT 84604-3380 Ph: (801) 357-7850 |
News Archive
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
Researchers have recently used an artificial intelligence (AL) technique to examine how MRI scans can validate how hereditary factors can impact heart function.
Wolters Kluwer Health, a division of Wolters Kluwer, has released the results of a study that looks at key statistical outcomes of the Medicare Part D (MPD) prescription drug program.
The U.S. Food and Drug Administration today issued a Federal Register notice instructing companies to stop manufacturing and distributing certain unapproved drugs that contain oxycodone. The notice is part of the FDA's Unapproved Drugs Initiative to remove unapproved new drugs from the market.
› Verified 6 days ago
Adam R Krommenhoek, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-373-7850 | |
Craig P Patten, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 North 500 West, Provo, UT 84604 Phone: 801-373-7850 | |
Robert D Christensen, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 | |
Andrew Pressman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-357-7850 | |
Mr. Tanner Lee Frey, PHYSICIAN ASSISTANT Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-358-1076 | |
Dr. Cameron Royall, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1034 N 500 W, Provo, UT 84604 Phone: 801-362-4119 |